Draper Asset Management, LLC Invitae Corp Call Options Transaction History

Draper Asset Management, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 02, 2023	SELL	$0.6 - $1.53 $60 - $153	-100 Reduced 0.99%	10,000 $6,000
Q2 2023 Aug 02, 2023	SELL	$1.05 - $1.63 $525 - $815	-500 Reduced 4.72%	10,100 $11,000
Q1 2023 May 05, 2023	SELL	$1.2 - $2.73 $9,600 - $21,840	-8,000 Reduced 43.01%	10,600 $14,000
Q4 2022 Feb 08, 2023	BUY	$1.71 - $3.61 $31,806 - $67,146	18,600 New	18,600 $34,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $21,087 - $89,199	9,900 Added 110.0%	18,900 $11,000
Q1 2022 May 13, 2022	SELL	$6.28 - $15.59 $3,768 - $9,354	-600 Reduced 6.25%	9,000 $9,000
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $119,070 - $232,227	8,100 Added 540.0%	9,600 $31,000
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $12,155 - $16,800	500 Added 50.0%	1,500 $5,000
Q1 2021 May 17, 2021	BUY	$33.06 - $56.93 $33,060 - $56,930	1,000 New	1,000 $15,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Draper Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Draper Asset Management, LLC with notifications on news.